GSK and Medicines for Malaria Venture (MMV) announce FDA approval of single-dose treatment Krintafel (tafenoquine) to prevent the relapse of P. vivax malaria.

WWARN's Clinical Group has published results supporting the need for a radical cure strategy to tackle one of the most debilitating forms of malaria caused by the Plasmodium vivax parasite.

The WWARN network is very saddened by the news of the passing of Prof Ogobara Doumbo on Saturday 9 June in Marseille, France. Prof Doumbo was a long-standing WWARN partner and highly respected for his contribution to the malaria community through co-founding the Centre for Malaria Research & Trainin...

Our surveyors and explorers are currently unavailable due to a technical issue. We are working to get this issue resolved as soon as possible and apologise for the inconvenience.

WWARN’s Clinical Group led by Professor Ric Price joined government ministers, international institutes, malaria experts and civil society organisations in Melbourne Australia for the First Malaria World Congress 1-5 July 2018. Discussions focussed on elimination efforts, cross-sectoral collaboratio...

Current recommended treatment regimens for the most widely used medicine for uncomplicated Plasmodium falciparum malaria may be sub-optimal for small children and pregnant women according to a study led by Prof. Joel Tarning, Head of Pharmacometrics at the WorldWide Antimalarial Resistance Network (...

A pioneering conference will bring leading professionals from all over the world to Oxford, UK to discuss strategies for tackling poor quality medical products on a global scale.

Additional research in Equatorial Guinea shows that screening technology commonly used in the region cannot detect parasites in most of the contaminated supplies.

The World Health Organization (WHO) recommended in 2012 to add single low-dose primaquine (SLDPQ) to standard artemisinin based combination treatments (ACTs) to block the transmission of Plasmodium falciparum malaria. The target dose of 0.25 mg base/kg body weight (15 mg in a 60 kg adult) was consid...

The Commonwealth Malaria Summit last week in London (part of CHOGM 2018) welcomed Bill Gates and 12 Heads of State, 2 Deputy Heads of State and many international organisations on Wednesday 18th April. This fantastic event resulted in more than £2.9bn / $4.1bn pledged from Governments, the private s...

We had a fantastic time at the Multilateral Initiative on Malaria’s 7th Pan-African meeting in Dakar, Senegal, 15-20 April, 2018. Thank you for joining us!

Global health officials could improve surveillance of antimalarial resistance by applying new technologies for conducting in vitro and molecular studies, and supporting national reference laboratories in malaria-endemic countries, a recently published review reports.

Children suffering from malaria and malnutrition might experience diminished height growth when treated for both conditions simultaneously, according to a recently published article.

A new study published today reveals the challenges of establishing sustainable and effective networks to tackle resistance to antimicrobial medicines in low- and middle-income countries (LMICs).

The fourth Quality of Medical Products and Public Health course will take place in Oxford this year, from 17-21 September, at Wolfson College. This multidisciplinary course is aimed at professionals who are interested in the quality of medical products. The application deadline is 18 May.

Researchers seeking to boost malaria control and elimination efforts in the Greater Mekong Subregion (GMS) have demonstrated the feasibility of obtaining close to real-time information on the prevalence and distribution of molecular markers of resistance to Artemisinin Combination Therapies (ACTs).

After convening 44 clinical research professionals from 20 countries who share the common goal of improving the quality of their data, coordinators of the ground-breaking Newton workshop in Nairobi said they hoped to hold similar sessions in the future, to help provide the skills and networks needed...

Seeking to support data management skills development among early- to mid-career malaria researchers, WWARN will host a free practical workshop in April at the Multilateral Initiative on Malaria (MIM) 2018 meeting in Dakar, Senegal.

Resistance to the commonly used antimalarial treatment artesunate might have contributed to the death of a patient suffering from severe malaria on the Thailand-Myanmar border, a recently published article reveals.

A systematic review of research on treatments for malaria in pregnancy has suggested new approaches to analysing available efficacy data and to assessing and reporting safety in studies, two recently published articles report.